Abstract:Background: Accelerated progression of residual hepatocellular carcinoma (HCC) after incomplete radiofrequency ablation (RFA) has been reported more frequently. Recent data have redefined the concept of inflammation as a critical component of tumor progression. However, there has been little understanding regarding the relationship between progression of residual HCC and the inflammation induced by thermal destruction of the tumor after RFA. The present study was designed to determine whether inflammation facilitates rapid progression of residual hepatic VX2 carcinoma and to clarify the possible underlying mechanisms. Methods: Forty-eight rabbits were each implanted with two VX2 hepatic tumors via supraumbilical median laparotomy. One of the tumors in two different lobes was ablated by RFA. All the rabbits were then randomly divided into four groups (12 rabbits in each group) receiving anti-inflammatory treatment with different doses of aspirin: control group, AS-L group (aspirin, 5 mg/kg/d), AS-M group (aspirin, 20 mg/kg/d), and AS-H group (aspirin, 100 mg/kg/d). The levels of serum interleukin-6 (IL-6), high sensitivity C-reactive protein (hs-CRP), and tumor necrosis factor-α (TNF-α) were detected to evaluate the effect of the anti-inflammation. Tumor growth, lung and kidney metastasis, and survival were assessed. The expression of proliferating cell nuclear antigen (PCNA), matrix metalloproteinase 9 (MMP-9), vascular endothelial growth factor (VEGF), and cysteinyl aspartate specific proteinase 3 (caspase-3) in residual tumor was examined by immunohistochemistry and Western-blotting. Results: The levels of serum IL-6, hs-CRP, and TNF-α in the AS-H group decreased significantly in comparison with those of the control group (P<0.05). The focal tumor volume and lung and kidney metastases of rabbits in the AS-H group were less significant compared with those of the control group (P<0.05). The expression of PCNA, MMP-9, and VEGF in the AS-H group decreased significantly compared with the control group (P<0.05). Finally, the survival time of the AS-H group was longer than that of the control group (P<0.05). Conclusions: Inflammation induced by thermal destruction of the tumor following RFA could be an important cause of rapid progression of residual hepatic VX2 carcinoma. The anti-inflammation effect of aspirin can inhibit proliferation, invasion, and metastasis of residual tumor cells, and aspirin may be a good candidate drug as an adjuvant therapy with RFA for treating HCC.

The Role and Mechanism of Low-Dose Aspirin with IFN-α in Inhibiting Growth and Metastasis of Hepatocellular Carcinoma

Mechanism of Interferon Alpha on Inhibition of Metastasis and Angiogenesis of Hepatocellular Carcinoma after Curative Resection in Nude Mice

Aspirin Inhibits Cancer Metastasis and Angiogenesis Via Targeting Heparanase

Interferon-α Significantly Inhibits the Hepatocyte Growth Factor and Vascular Endothelial Growth Factor Expression in the Hepatocellular Carcinoma of Nude Mice Model with Highly Metastatic Potential

Aspirin in Hepatocellular Carcinoma: is It an Out-of-date or Promising Treatment?

High-Dose and Long-Term Therapy with Interferon-Alfa Inhibits Tumor Growth and Recurrence in Nude Mice Bearing Human Hepatocellular Carcinoma Xenografts with High Metastatic Potential

Direct Transformation of Lung Microenvironment by Interferon-Α Treatment Counteracts Growth of Lung Metastasis of Hepatocellular Carcinoma.

Long-term Interferon-Α Treatment Suppresses Tumor Growth but Promotes Metastasis Capacity in Hepatocellular Carcinoma.

Long-Term Interferon-Alpha Treatment Suppresses Tumor Growth But Promotes Metastasis Capacity In Hepatocellular Carcinoma

Aspirin enhances IFN-α-induced growth inhibition and apoptosis of hepatocellular carcinoma via JAK1/STAT1 pathway

Interferon alpha inhibits hepatocellular carcinoma growth through inducing apoptosis and interfering with adhesion of tumor endothelial cells.

Interferon-α Combined with Herbal Compound "songyou Yin" Effectively Inhibits the Increased Invasiveness and Metastasis by Insufficient Radiofrequency Ablation of Hepatocellular Carcinoma in an Animal Model.

Aspirin Minimized the Pro-Metastasis Effect of Sorafenib and Improved Survival by Up-Regulating Htatip2 in Hepatocellular Carcinoma

Effect of Interferon-Α and All-Trans Retinoic Acid on Recurrence and Metastasis of Hepatocellular Carcinoma

Data from Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib Plus NK Cells Immunotherapy to Better Suppress HCC Progression

HIF-1 α RNAi Combined with Asparagus Polysaccharide Exerts an Antiangiogenesis Effect on Hepatocellular Carcinoma In Vitro and In Vivo

Inhibition of Human Hepatocellular Carcinoma Tumor Angiogenesis by Sirna Silencing of VEGF Via Hepatic Artery Perfusion.

Herbal Compound "songyou Yin" Reinforced the Ability of Interferon-Alfa to Inhibit the Enhanced Metastatic Potential Induced by Palliative Resection of Hepatocellular Carcinoma in Nude Mice.

Aspirin suppresses hepatocellular carcinoma progression by inhibiting platelet activity

Antiangiogenic Therapy Promoted Metastasis of Hepatocellular Carcinoma by Suppressing Host-Derived Interleukin-12B in Mouse Models

Inflammation and cancer: inhibiting the progression of residual hepatic VX2 carcinoma by anti-inflammatory drug after incomplete radiofrequency ablation